Roidipedia.Compound reference & reporting
06 AUG 2026
CompoundsResearch chemical 2C-T-13
Research chemicalPsychedelicThioether2C-T phenethylamine

2C-T-13

Also known as 2,5-dimethoxy-4-(2-methoxyethylthio)phenethylamine

2C-T-13 is a 2-methoxyethylthio 2C-T analogue described by Shulgin as a gentle, insightful psychedelic. It is obscure, rarely encountered, and has no safety data.

01 Overview

2C-T-13 carries a 4-(2-methoxyethylthio) substituent on the 2C phenethylamine core. Shulgin's notes describe a mild, thoughtful effect at moderate doses. It never circulated widely and remains a footnote in the 2C-T series.

As with all 2C-T compounds, MAO-dependent metabolism means MAOI combinations are hazardous, and no toxicology has been performed.

02 Mechanism

Partial agonist at 5-HT2A/2C receptors; the methoxyethylthio group gives moderate potency.

03 Dosing

TierDoseRouteNotes
Reported common25–40 mgOralShulgin range.

04 Effects

EffectMagnitudeEvidence
Gentle psychedeliaSoft visual and cognitive effects described as insightful.mild-moderateAnecdotal
RelaxationCalm, contemplative tone in favourable reports.mildAnecdotal

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
NauseaOnset gastric discomfort typical of the class.MildCommonAnecdotal
MAOI interaction riskCombining with MAOIs risks serotonergic/hypertensive crisis.Life-threateningRareAnecdotal

07 References

PiHKAL: A Chemical Love Story (2C-T-13 entry)Shulgin & Shulgin, 1991

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.